Filter
684
Filtered Results: 684
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
65
New Publications
204
Language
Document type
No document type
345
Studies & Reports
129
Guidelines
103
Manuals
43
Strategic & Response Plan
41
Training Material
9
Fact sheets
9
Situation Updates
3
Resource Platforms
2
Countries / Regions
Global
36
India
35
Kenya
31
Ethiopia
27
Uganda
17
South Africa
15
Western and Central Europe
13
Nepal
11
Tanzania
11
Namibia
11
Sierra Leone
10
Nigeria
10
Philippines
10
Liberia
10
Ghana
9
Zambia
9
Bangladesh
8
Ukraine
7
Rwanda
7
Myanmar / Burma
7
Zimbabwe
6
Africa
6
Indonesia
6
Syria
5
South Sudan
5
Lesotho
4
Malawi
4
Cambodia
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Cameroon
3
Senegal
3
Congo, Democratic Republic of
3
South–East Asia Region
3
Eswatini/ Swaziland
3
Thailand
2
Fiji
2
Laos
2
Burkina Faso
2
Mozambique
2
Asia
2
Latin America and the Carribbean
2
Jordan
2
West and Central Africa
2
Vietnam
2
Botswana
2
Pakistan
2
Timor Leste/ East Timor
1
Australia
1
Benin
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
USA
1
Haiti
1
Lithuania
1
Belgium
1
United Kingdom
1
East and Southern Africa
1
Lebanon
1
Brazil
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
283
Key Resources
43
Clinical Guidelines
37
Public Health
30
Women & Child Health
21
Pharmacy & Technologies
9
Capacity Building
7
Toolboxes
Pharmacy
65
AMR
59
COVID-19
31
NTDs
31
HIV
29
Mental Health
28
TB
28
Planetary Health
28
Rapid Response
19
NCDs
17
Health Financing Toolbox
14
Conflict
13
Caregiver
11
Malaria
11
Ebola & Marburg
9
Global Health Education
9
Specific Hazards
6
Disability
5
Refugee
3
Natural Hazards
3
2.0 Rapid Response
3
Social Ethics
2
South Sudan
1
Zika
1
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at high-level United Nations meetings. It highlights ...
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. T...
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
Volume 2019, Article ID 4157574, 7 pages
https://doi.org/10.1155/2019/4157574
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
A call for national and regional containment, recovery and prevention
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...
A Handbook for country programmes
Accessed Febr. 6, 2020
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
